Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Headache|February 1, 2024
Substance use in a Dutch migraine cohort compared with the general populationThomas C van den Hoek, Iris E Verhagen, Irene de Boer, et al.
Cephalalgia : an International Journal of Headache|January 12, 2021
Effect of lockdown during COVID-19 on migraine: A longitudinal cohort studyIris E Verhagen, Daphne S van Casteren, Simone de Vries Lentsch, et al.
Cephalalgia : an International Journal of Headache|November 18, 2020
Sex differences in prevalence of migraine trigger factors: A cross-sectional studyDaphne S van Casteren, Iris E Verhagen, Gerrit Lj Onderwater, et al.
The Journal of Headache and Pain|October 20, 2021
Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort studyIris E Verhagen, Roemer B Brandt, Carlijn M A Kruitbosch, et al.
European Journal of Neurology|August 23, 2021
Treatment with the monoclonal calcitonin gene-related peptide receptor antibody erenumab: A real-life studySimone de Vries Lentsch, Iris E Verhagen, Thomas C van den Hoek, et al.
Trials|February 15, 2024
Continuous combined oral contraceptive use versus vitamin E in the treatment of menstrual migraine: rationale and protocol of a randomized controlled trial (WHAT!)Britt W H van der Arend, Daphne S van Casteren, Iris E Verhagen, et al.
Cephalalgia : an International Journal of Headache|May 6, 2022
Validation of diagnostic ICHD-3 criteria for menstrual migraineIris E Verhagen, Hermes Aj Spaink, Britt Wh van der Arend, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|July 15, 2024
Practical Experience with the Use of Electronic Headache Diaries and Video Consultations in Migraine Care from a Longitudinal Cohort StudyBritt W H van der Arend, Linde J Holwerda, Iris E Verhagen, et al.
Headache|March 21, 2023
Sex differences in migraine attack characteristics: A longitudinal E-diary studyIris E Verhagen, Britt W H van der Arend, Daphne S van Casteren, et al.
European Journal of Neurology|March 21, 2023
Both perimenstrual and nonperimenstrual migraine days respond to anti-calcitonin gene-related peptide (receptor) antibodiesIris E Verhagen, Simone de Vries Lentsch, Britt W H van der Arend, et al.
Pageof 2